Senti Biosciences
SNTI
SNTI
25 hedge funds and large institutions have $5.02M invested in Senti Biosciences in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
34% less capital invested
Capital invested by funds: $7.64M → $5.02M (-$2.62M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
25
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$48.1K | |
| 2 | +$16.2K | |
| 3 | +$13K | |
| 4 |
TM
Triatomic Management
Palo Alto,
California
|
+$4.13K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$83 |
Top Sellers
| 1 | -$105K | |
| 2 | -$22K | |
| 3 | -$11K | |
| 4 |
Morgan Stanley
New York
|
-$10.7K |
| 5 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
-$8.28K |